Four human tumor cell lines, derived from breast (T-47D), prostate (PC-3), epidermal (A431) and colorectal (HCT116) cancers, were employed and their response to the inhibition of Stat5 was investigated. This evidence concerns the gene STAT5B and neoplasm.